# Short-Chain Fatty Acids in Lypopolysaccharide-Induced Inflammation and Executive Function

> **NCT07713641** · NA · RECRUITING · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 56 (estimated)

## Conditions studied

- Endotoxemia
- Inflammation
- Executive Function (Cognition)

## Interventions

- **DIETARY_SUPPLEMENT:** Short-Chain Fatty Acid Colon-Delivery Capsules
- **DIETARY_SUPPLEMENT:** Placebo capsules
- **BIOLOGICAL:** Lipopolysaccharide (LPS)

## Key facts

- **NCT ID:** NCT07713641
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-24
- **Primary completion:** 2027-03-30
- **Final completion:** 2027-03-30
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-07-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07713641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07713641, "Short-Chain Fatty Acids in Lypopolysaccharide-Induced Inflammation and Executive Function". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07713641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*